EnJun Yang, PhD

EnJun Yang, PhD, is the Research Director at the Parker Institute for Cancer Immunotherapy (PICI). He develops and manages the institute’s diverse partnerships with academic researchers, companies and investors to ensure the delivery of projects and programs across the immuno-oncology space. His focus is on enabling and accelerating data-driven decisions by individual stakeholders and leadership to execute PICI’s various collaborative programs.

EnJun is proficient with molecular and cellular immunology techniques, and specializes in the planning and execution of long- and short-read RNA and DNA sequencing projects at both the bulk and single-cell level. Aside from his laboratory experiments, EnJun has spearheaded, maintained and delivered multiple on-premises and cloud-based analytics pipelines to fulfill key research collaborative agreements with various companies, start-ups and academic colleagues.

Prior to PICI, EnJun held postdoctoral fellowships at the Genome Institute of Singapore and the Institute of Molecular and Cell Biology in Singapore. Between his postdoctoral positions, he was the head of the data team at Tessa Therapeutics, an immunotherapy-based startup in Singapore.

Before working in Singapore, EnJun earned his PhD in immunology from the University of Pennsylvania, and his BS in biology from the University of Michigan. With his expertise in large-scale biological datasets and his experience managing cooperative research across multiple groups, EnJun aims to support PICI’s partners and effectively evaluate and expand their data capabilities.